These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 22171586
21. Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes. Kim J, Lee S, Bae S, Choi MY, Lee J, Jung SP, Kim S, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH. Breast Cancer Res Treat; 2012 Jan; 131(2):527-40. PubMed ID: 22042364 [Abstract] [Full Text] [Related]
22. A long-term survival pattern for breast cancer treated in a single institution. Gokce T, Karadogan I, Akcay C. Indian J Cancer; 2011 Jan; 48(2):187-93. PubMed ID: 21768664 [Abstract] [Full Text] [Related]
24. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients]. Zhang P, Xu BH, Ma F, Li Q, Yuan P, Wang JY, Zhang P. Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471 [Abstract] [Full Text] [Related]
25. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods. Skowronek J, Piotrowski T. Neoplasma; 2002 May; 49(6):426-31. PubMed ID: 12584593 [Abstract] [Full Text] [Related]
27. A prognostic model to predict outcome of patients failing to achieve pathological complete response after anthracycline-containing neoadjuvant chemotherapy for breast cancer. Chen S, Chen CM, Yu KD, Yang WT, Shao ZM. J Surg Oncol; 2012 May; 105(6):577-85. PubMed ID: 22065549 [Abstract] [Full Text] [Related]
29. [Treatment of breast cancer during pregnancy]. Espié M, Cuvier C. Contracept Fertil Sex; 1996 Nov; 24(11):805-10. PubMed ID: 8991583 [Abstract] [Full Text] [Related]
30. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study. Bandić D, Juretić A, Sarcević B, Separović V, Kujundzić-Tiljak M, Hudolin T, Spagnoli GC, Cović D, Samija M. Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695 [Abstract] [Full Text] [Related]
31. Prognosis of HER2-positive pregnancy-associated breast cancer: Analysis from the French CALG (Cancer Associé à La Grossesse) network. Boudy AS, Ferrier C, Selleret L, Zilberman S, Arfi A, Sussfeld J, Gligorov J, Richard S, Bendifallah S, Chabbert-Buffet N, Touboul C, Daraï E. Breast; 2020 Dec; 54():311-318. PubMed ID: 33271423 [Abstract] [Full Text] [Related]
35. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes]. Zhang HM, Zhang BN, Xuan LX, Zhao P. Zhonghua Zhong Liu Za Zhi; 2009 Jun 01; 31(6):447-51. PubMed ID: 19950556 [Abstract] [Full Text] [Related]
36. Younger women with breast carcinoma have a poorer prognosis than older women. Chung M, Chang HR, Bland KI, Wanebo HJ. Cancer; 1996 Jan 01; 77(1):97-103. PubMed ID: 8630946 [Abstract] [Full Text] [Related]
37. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis. Chapman JA, Lickley HL, Trudeau ME, Hanna WM, Kahn HJ, Murray D, Sawka CA, Mobbs BG, McCready DR, Pritchard KI. Breast J; 2006 Jan 01; 12(1):37-47. PubMed ID: 16409585 [Abstract] [Full Text] [Related]